Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
about
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@en
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@nl
type
label
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@en
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@nl
prefLabel
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@en
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
@nl
P1050
P3098
NCT03450967